Condition: Safety and Tolerability in Healthy Volunteers · Sponsor: Bactolife A/S
This study is the first-in human study for the food ingredient BP-CBB and aims aims to build on the excellent safety and tolerability observed in the extensive food safety assessment performed for BP-CBB, as well as the consumer experience with using the product, and to set the scene for future human studies documenting the health-benefits of daily supplementation with BP-CBB for diverse populations.
This description comes directly from the study's public registry record.
Emma Harrington · +353 (0) 86-218-8787 · eharrington@atlantiatrials.com
Emily Goodbody · +353 (0) 86-218-8787 · egoodbody@atlantiatrials.com
Always discuss trial participation with your own doctor first.
| Atlantia Clinical Trials | Cork, Ireland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07628608